English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Hepatocellular carcinoma (HCC) is the sixth most common tumor type and the third leading cause of death related to cancer worldwide (1). Up to half of all HCC cases occur in China, and there were a total of 782,500 new liver cancer cases and 745,500 deaths worldwide in 2012, with 84.6% of liver cancer incidence and 86.3% of liver cancer deaths in the WHO Western Pacific region (WPRO) occurring Original Article

Low expression of citron kinase is associated with poor patient outcomes in hepatocellular carcinoma